Skip to main content

Attention-Deficit Hyperactivity Disorder (ADHD) News (Page 6)

Related terms: ADHD, Attention Deficit Disorder, Childhood hyperkinesis, ADD

FDA Approves Daytrana (methylphenidate transdermal system) CII for the Treatment of ADHD in Adolescents

DUBLIN and PHILADELPHIA, July 6 /PRNewswire-FirstCall/ – Shire plc , the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana...

Shire Announces FDA Approval of Once-Daily Intuniv (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17

PHILADELPHIA, September 3/PRNewswire-FirstCall/ – Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration...

FDA Medwatch Alert: Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder - Communication about an Ongoing Safety Review

Products involved include: Focalin, Focalin XR (dexmethylphenidate HCl ); Dexedrine, Dexedrine Spansules, Dextroamphetamine ER, Dextrostat (dextroamphetamine sulfate); Vyvanse (lisdexamfetamine...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Oppositional Defiant Disorder

Related drug support groups

Adderall, bupropion, Vyvanse, amphetamine, Adderall XR, Concerta, methamphetamine, Ritalin, Strattera, view more... clonidine, methylphenidate, modafinil, dextroamphetamine, amphetamine / dextroamphetamine, guanfacine, amantadine, 5-HTP, desvenlafaxine, Focalin, Focalin XR